Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917801 (
insomnia
)
10,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The purpose of the work was assessment of clinical efficiency of OT and study of cerebral blood flow indices in combined treatment of
DEP
patients, including OT. It was detected that addition of intravenous OT in a complex of planned therapy of
DEP
patients at the age about 60 years leaded to more significant and more rapid (vs. control groups) regress of
DEP
symptoms, in the first place headache, ear noise,
sleeplessness
, memory reduce. Decrease in objective manifestation of neurological syndromes such as dysmnesic, akineticorigid, asthenic ones. Blood lipid spectrum, blood glucose level, blood coagulant system and cerebral blood flow indices were improved. These effects were more expressive in patients with the age less than 60 years. In control subgroups these changes were less expressed. Thus, of OT in combined treatment of patients with
DEP
improved efficiency of drug therapy and accelerated regress of various symptoms of this pathology, especially in patients with the age less than 60 years.
...
PMID:[Use of ozonotherapy (OT) in combined treatment of patients with discirculatory encephalopathy (DEP)]. 1850 80